References:1. IMS Health National Prescription Audit, August 2010. Data is proprietary to
IMS Health.
2. Ford C, Goodman AD, Johnson K, et al.
Mult Scler. 2010;16(3):342-350.
3. Data on file. Teva Neuroscience, Inc.
4. Weber MS, Hohlfeld R, Zamvil SS.
Neurotherapeutics. 2007;4(4):647-653.
5. Miller A, Shapiro S, Gershtein R, et al.
J Neuroimmunol. 1998;92(1-2):113-121.
6. COPAXONE
® (glatiramer acetate injection) prescribing information. Teva Neuroscience, Inc.